NanoViricides
NNVC
#10132
Rank
A$33.5 M
Marketcap
A$1.86
Share price
0.82%
Change (1 day)
-17.75%
Change (1 year)

P/E ratio for NanoViricides (NNVC)

P/E ratio as of December 2025 (TTM): -1.87

According to NanoViricides's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.86567. At the end of 2024 the company had a P/E ratio of -2.64.

P/E ratio history for NanoViricides from 2006 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-2.6456.46%
2023-1.69-39.67%
2022-2.80-51.43%
2021-5.7784.96%
2020-3.1252.61%
2019-2.04-38.72%
2018-3.33-60.09%
2017-8.35-3.81%
2016-8.68-80.15%
2015-43.8202.88%
2014-14.410.44%
2013-13.10.09%
2012-13.1-50.63%
2011-26.5-46.26%
2010-49.269.83%
2009-29.0-55.38%
2008-65.0111.96%
2007-30.7-44.24%
2006-55.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
BioCryst Pharmaceuticals
BCRX
-150 7,944.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
3.21-272.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
18.6-1,098.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.6-1,045.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
13.2-805.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
13.4-819.58%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.